ID   PCY1A_RAT               Reviewed;         367 AA.
AC   P19836;
DT   01-FEB-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 2.
DT   02-OCT-2024, entry version 183.
DE   RecName: Full=Choline-phosphate cytidylyltransferase A;
DE            EC=2.7.7.15 {ECO:0000269|PubMed:12718547, ECO:0000269|PubMed:19783652, ECO:0000269|PubMed:2166941, ECO:0000269|PubMed:24275660, ECO:0000269|PubMed:639816, ECO:0000269|PubMed:8185307, ECO:0000269|PubMed:8381041};
DE   AltName: Full=CCT-alpha;
DE   AltName: Full=CTP:phosphocholine cytidylyltransferase A;
DE            Short=CCT A;
DE            Short=CT A;
DE   AltName: Full=Phosphorylcholine transferase A;
GN   Name=Pcyt1a; Synonyms=Ctpct, Pcyt1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, FUNCTION, AND
RP   CATALYTIC ACTIVITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=2166941; DOI=10.1073/pnas.87.16.6029;
RA   Kalmar G.B., Kay R.J., Lachance A., Aebersold R., Cornell R.B.;
RT   "Cloning and expression of rat liver CTP:phosphocholine
RT   cytidylyltransferase: an amphipathic protein that controls
RT   phosphatidylcholine synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:6029-6033(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Lung;
RA   Hogan M., Zimmermann L.J., Wang J., Kuliszewski M., Liu J., Buch S.,
RA   Post M.;
RL   Submitted (NOV-1993) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND ACTIVITY
RP   REGULATION.
RX   PubMed=8381041; DOI=10.1006/prep.1993.1001;
RA   Macdonald J.I.S., Kent C.;
RT   "Baculovirus-mediated expression of rat liver CTP:phosphocholine
RT   cytidylyltransferase.";
RL   Protein Expr. Purif. 4:1-7(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=639816; DOI=10.1111/j.1432-1033.1978.tb12227.x;
RA   Choy P.C., Schneider W.J., Vance D.E.;
RT   "Immunological studies on CTP:phosphocholine cytidylyltransferase from the
RT   livers of normal and choline-deficient rats.";
RL   Eur. J. Biochem. 85:189-193(1978).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, PHOSPHORYLATION, SUBCELLULAR LOCATION,
RP   BIOPHYSICOCHEMICAL PROPERTIES, ACTIVITY REGULATION, AND MUTAGENESIS OF
RP   SER-362.
RX   PubMed=8185307; DOI=10.1006/abbi.1994.1215;
RA   Sweitzer T.D., Kent C.;
RT   "Expression of wild-type and mutant rat liver CTP: phosphocholine
RT   cytidylyltransferase in a cytidylyltransferase-deficient Chinese hamster
RT   ovary cell line.";
RL   Arch. Biochem. Biophys. 311:107-116(1994).
RN   [7]
RP   PHOSPHORYLATION AT SER-315; SER-319; SER-321; SER-322; SER-323; SER-329;
RP   SER-331; SER-333; SER-343; SER-345; SER-346; SER-347; SER-350; SER-352 AND
RP   SER-362.
RC   TISSUE=Liver;
RX   PubMed=8144639; DOI=10.1016/s0021-9258(17)34092-9;
RA   McDonald J.I.S., Kent C.;
RT   "Identification of phosphorylation sites in rat liver CTP: phosphocholine
RT   cytidylyltransferase.";
RL   J. Biol. Chem. 269:10529-10537(1994).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF LYS-122.
RX   PubMed=12718547; DOI=10.1021/bi027431+;
RA   Helmink B.A., Braker J.D., Kent C., Friesen J.A.;
RT   "Identification of lysine 122 and arginine 196 as important functional
RT   residues of rat CTP:phosphocholine cytidylyltransferase alpha.";
RL   Biochemistry 42:5043-5051(2003).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-319; SER-331; THR-342;
RP   SER-347 AND SER-362, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [10]
RP   STRUCTURE BY NMR OF 236-268.
RC   TISSUE=Liver;
RX   PubMed=8810902; DOI=10.1021/bi960821+;
RA   Dunne S.J., Cornell R.B., Johnson J.E., Glover N.R., Tracey A.S.;
RT   "Structure of the membrane binding domain of CTP:phosphocholine
RT   cytidylyltransferase.";
RL   Biochemistry 35:11975-11984(1996).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 1-236 IN COMPLEX WITH
RP   CDP-CHOLINE, FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF HIS-168 AND
RP   TYR-173, SUBUNIT, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=19783652; DOI=10.1074/jbc.m109.053363;
RA   Lee J., Johnson J., Ding Z., Paetzel M., Cornell R.B.;
RT   "Crystal structure of a mammalian CTP: phosphocholine cytidylyltransferase
RT   catalytic domain reveals novel active site residues within a highly
RT   conserved nucleotidyltransferase fold.";
RL   J. Biol. Chem. 284:33535-33548(2009).
RN   [12] {ECO:0007744|PDB:4MVC, ECO:0007744|PDB:4MVD}
RP   X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 1-312 IN COMPLEX WITH
RP   CDP-CHOLINE, FUNCTION, CATALYTIC ACTIVITY, PATHWAY, SUBUNIT, AND ACTIVITY
RP   REGULATION.
RX   PubMed=24275660; DOI=10.1074/jbc.m113.526970;
RA   Lee J., Taneva S.G., Holland B.W., Tieleman D.P., Cornell R.B.;
RT   "Structural basis for autoinhibition of CTP:phosphocholine
RT   cytidylyltransferase (CCT), the regulatory enzyme in phosphatidylcholine
RT   synthesis, by its membrane-binding amphipathic helix.";
RL   J. Biol. Chem. 289:1742-1755(2014).
CC   -!- FUNCTION: Catalyzes the key rate-limiting step in the CDP-choline
CC       pathway for phosphatidylcholine biosynthesis.
CC       {ECO:0000269|PubMed:12718547, ECO:0000269|PubMed:19783652,
CC       ECO:0000269|PubMed:2166941, ECO:0000269|PubMed:24275660,
CC       ECO:0000269|PubMed:639816, ECO:0000269|PubMed:8185307,
CC       ECO:0000269|PubMed:8381041}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=CTP + H(+) + phosphocholine = CDP-choline + diphosphate;
CC         Xref=Rhea:RHEA:18997, ChEBI:CHEBI:15378, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:37563, ChEBI:CHEBI:58779, ChEBI:CHEBI:295975;
CC         EC=2.7.7.15; Evidence={ECO:0000269|PubMed:12718547,
CC         ECO:0000269|PubMed:19783652, ECO:0000269|PubMed:2166941,
CC         ECO:0000269|PubMed:24275660, ECO:0000269|PubMed:639816,
CC         ECO:0000269|PubMed:8185307, ECO:0000269|PubMed:8381041};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18998;
CC         Evidence={ECO:0000305|PubMed:19783652, ECO:0000305|PubMed:24275660};
CC   -!- ACTIVITY REGULATION: Interconverts between an inactive cytosolic form
CC       and an active membrane-bound form (PubMed:24275660). Activation
CC       involves disruption of an inhibitory interaction between helices at the
CC       base of the active site and the autoinhibitory (AI) region
CC       (PubMed:24275660). Activated by N-methylethanolamine (PubMed:8185307).
CC       Activated by oleic acid-containing phosphatidylcholine vesicles
CC       (PubMed:8381041). {ECO:0000269|PubMed:24275660,
CC       ECO:0000269|PubMed:8185307, ECO:0000269|PubMed:8381041}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.41 uM for CTP {ECO:0000269|PubMed:8185307};
CC         KM=0.47 uM for phosphocholine {ECO:0000269|PubMed:8185307};
CC   -!- PATHWAY: Phospholipid metabolism; phosphatidylcholine biosynthesis;
CC       phosphatidylcholine from phosphocholine: step 1/2.
CC       {ECO:0000269|PubMed:12718547, ECO:0000269|PubMed:19783652,
CC       ECO:0000269|PubMed:2166941, ECO:0000269|PubMed:24275660,
CC       ECO:0000269|PubMed:639816, ECO:0000269|PubMed:8185307,
CC       ECO:0000269|PubMed:8381041}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:19783652,
CC       ECO:0000269|PubMed:24275660}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:639816}.
CC       Membrane {ECO:0000269|PubMed:24275660, ECO:0000269|PubMed:639816};
CC       Peripheral membrane protein {ECO:0000269|PubMed:639816}. Endoplasmic
CC       reticulum membrane {ECO:0000250|UniProtKB:P49585}; Peripheral membrane
CC       protein {ECO:0000269|PubMed:639816}. Nucleus
CC       {ECO:0000269|PubMed:8185307}. Note=It can interconvert between an
CC       inactive cytosolic form and an active membrane-bound form.
CC       {ECO:0000269|PubMed:24275660}.
CC   -!- PTM: The serine residues of the C-terminus are phosphorylated. The
CC       inactive soluble form is stabilized by phosphorylation, the active
CC       membrane bound form is promoted by anionic lipids or diacylglycerol,
CC       and is stabilized by dephosphorylation. {ECO:0000269|PubMed:8144639}.
CC   -!- PTM: The N-terminus is blocked. {ECO:0000269|PubMed:2166941}.
CC   -!- PTM: Monoubiquitinated by the SCF(FBXL2) complex, leading to
CC       proteasomal degradation. {ECO:0000250|UniProtKB:P49586}.
CC   -!- MISCELLANEOUS: The cytidylyltransferase may interact with membranes
CC       through its amphipathic helix.
CC   -!- SIMILARITY: Belongs to the cytidylyltransferase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M36071; AAA40995.1; -; mRNA.
DR   EMBL; U03490; AAB60489.1; -; mRNA.
DR   EMBL; L13245; AAB59683.1; -; mRNA.
DR   EMBL; BC085713; AAH85713.1; -; mRNA.
DR   PIR; A36001; A36001.
DR   RefSeq; NP_511177.2; NM_078622.2.
DR   RefSeq; XP_006248506.1; XM_006248444.3.
DR   RefSeq; XP_008766916.1; XM_008768694.2.
DR   PDB; 1PEH; NMR; -; A=236-268.
DR   PDB; 1PEI; NMR; -; A=267-288.
DR   PDB; 3HL4; X-ray; 2.20 A; A/B=1-236.
DR   PDB; 4MVC; X-ray; 3.00 A; A/B=1-312.
DR   PDB; 4MVD; X-ray; 8.00 A; A/B/C/D/E/F/G/H=1-312.
DR   PDBsum; 1PEH; -.
DR   PDBsum; 1PEI; -.
DR   PDBsum; 3HL4; -.
DR   PDBsum; 4MVC; -.
DR   PDBsum; 4MVD; -.
DR   AlphaFoldDB; P19836; -.
DR   SMR; P19836; -.
DR   STRING; 10116.ENSRNOP00000002403; -.
DR   SwissLipids; SLP:000001188; -.
DR   iPTMnet; P19836; -.
DR   PhosphoSitePlus; P19836; -.
DR   jPOST; P19836; -.
DR   PaxDb; 10116-ENSRNOP00000002403; -.
DR   Ensembl; ENSRNOT00000002403.4; ENSRNOP00000002403.3; ENSRNOG00000001762.4.
DR   Ensembl; ENSRNOT00055029639; ENSRNOP00055023801; ENSRNOG00055017520.
DR   Ensembl; ENSRNOT00060042408; ENSRNOP00060035139; ENSRNOG00060024455.
DR   Ensembl; ENSRNOT00065035485; ENSRNOP00065028589; ENSRNOG00065020895.
DR   GeneID; 140544; -.
DR   KEGG; rno:140544; -.
DR   UCSC; RGD:70515; rat.
DR   AGR; RGD:70515; -.
DR   CTD; 5130; -.
DR   RGD; 70515; Pcyt1a.
DR   eggNOG; KOG2804; Eukaryota.
DR   GeneTree; ENSGT00940000157384; -.
DR   HOGENOM; CLU_034585_4_2_1; -.
DR   InParanoid; P19836; -.
DR   OMA; IWRESKG; -.
DR   OrthoDB; 5474784at2759; -.
DR   PhylomeDB; P19836; -.
DR   TreeFam; TF106336; -.
DR   BRENDA; 2.7.7.15; 5301.
DR   Reactome; R-RNO-1483191; Synthesis of PC.
DR   UniPathway; UPA00753; UER00739.
DR   EvolutionaryTrace; P19836; -.
DR   PRO; PR:P19836; -.
DR   Proteomes; UP000002494; Chromosome 11.
DR   Bgee; ENSRNOG00000001762; Expressed in skeletal muscle tissue and 19 other cell types or tissues.
DR   GO; GO:0005829; C:cytosol; IEA:UniProtKB-SubCell.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:RGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISO:RGD.
DR   GO; GO:0019898; C:extrinsic component of membrane; NAS:RGD.
DR   GO; GO:0042587; C:glycogen granule; ISO:RGD.
DR   GO; GO:0005635; C:nuclear envelope; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; IDA:RGD.
DR   GO; GO:0004105; F:choline-phosphate cytidylyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0008289; F:lipid binding; IMP:RGD.
DR   GO; GO:0140678; F:molecular function inhibitor activity; IDA:DisProt.
DR   GO; GO:0031210; F:phosphatidylcholine binding; IDA:RGD.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0042100; P:B cell proliferation; ISS:UniProtKB.
DR   GO; GO:0006657; P:CDP-choline pathway; IDA:UniProtKB.
DR   GO; GO:0045190; P:isotype switching; ISS:UniProtKB.
DR   GO; GO:0006656; P:phosphatidylcholine biosynthetic process; IDA:UniProtKB.
DR   CDD; cd02174; CCT; 1.
DR   DisProt; DP02118; -.
DR   Gene3D; 3.40.50.620; HUPs; 1.
DR   InterPro; IPR041723; CCT.
DR   InterPro; IPR004821; Cyt_trans-like.
DR   InterPro; IPR045049; Pcy1-like.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   NCBIfam; TIGR00125; cyt_tran_rel; 1.
DR   PANTHER; PTHR10739:SF19; CHOLINE-PHOSPHATE CYTIDYLYLTRANSFERASE A; 1.
DR   PANTHER; PTHR10739; CYTIDYLYLTRANSFERASE; 1.
DR   Pfam; PF01467; CTP_transf_like; 1.
DR   SUPFAM; SSF52374; Nucleotidylyl transferase; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Direct protein sequencing;
KW   Endoplasmic reticulum; Lipid biosynthesis; Lipid metabolism; Membrane;
KW   Nucleotidyltransferase; Nucleus; Phospholipid biosynthesis;
KW   Phospholipid metabolism; Phosphoprotein; Reference proteome; Repeat;
KW   Transferase; Ubl conjugation.
FT   CHAIN           1..367
FT                   /note="Choline-phosphate cytidylyltransferase A"
FT                   /id="PRO_0000208455"
FT   REPEAT          319..324
FT                   /note="1"
FT   REPEAT          329..333
FT                   /note="2; approximate"
FT   REPEAT          343..348
FT                   /note="3"
FT   REGION          1..31
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          228..287
FT                   /note="Amphipathic"
FT                   /evidence="ECO:0000305|PubMed:24275660"
FT   REGION          272..293
FT                   /note="Autoinhibitory (AI)"
FT                   /evidence="ECO:0000305|PubMed:24275660"
FT   REGION          298..315
FT                   /note="Amphipathic"
FT                   /evidence="ECO:0000305|PubMed:24275660"
FT   REGION          313..367
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          319..348
FT                   /note="3 X repeats"
FT   COMPBIAS        7..22
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        314..353
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         84
FT                   /ligand="CTP"
FT                   /ligand_id="ChEBI:CHEBI:37563"
FT                   /evidence="ECO:0000305|PubMed:19783652,
FT                   ECO:0000305|PubMed:24275660, ECO:0007744|PDB:3HL4,
FT                   ECO:0007744|PDB:4MVC, ECO:0007744|PDB:4MVD"
FT   BINDING         85
FT                   /ligand="CTP"
FT                   /ligand_id="ChEBI:CHEBI:37563"
FT                   /evidence="ECO:0000305|PubMed:19783652,
FT                   ECO:0000305|PubMed:24275660, ECO:0007744|PDB:3HL4,
FT                   ECO:0007744|PDB:4MVC, ECO:0007744|PDB:4MVD"
FT   BINDING         92
FT                   /ligand="CTP"
FT                   /ligand_id="ChEBI:CHEBI:37563"
FT                   /evidence="ECO:0000269|PubMed:19783652,
FT                   ECO:0007744|PDB:3HL4, ECO:0007744|PDB:4MVC,
FT                   ECO:0007744|PDB:4MVD"
FT   BINDING         122
FT                   /ligand="CTP"
FT                   /ligand_id="ChEBI:CHEBI:37563"
FT                   /evidence="ECO:0000269|PubMed:19783652,
FT                   ECO:0007744|PDB:3HL4, ECO:0007744|PDB:4MVC"
FT   BINDING         122
FT                   /ligand="phosphocholine"
FT                   /ligand_id="ChEBI:CHEBI:295975"
FT                   /evidence="ECO:0000305|PubMed:19783652,
FT                   ECO:0000305|PubMed:24275660, ECO:0007744|PDB:3HL4,
FT                   ECO:0007744|PDB:4MVC"
FT   BINDING         151
FT                   /ligand="phosphocholine"
FT                   /ligand_id="ChEBI:CHEBI:295975"
FT                   /evidence="ECO:0000305|PubMed:19783652,
FT                   ECO:0000305|PubMed:24275660, ECO:0007744|PDB:3HL4"
FT   BINDING         168
FT                   /ligand="CTP"
FT                   /ligand_id="ChEBI:CHEBI:37563"
FT                   /evidence="ECO:0000305|PubMed:19783652,
FT                   ECO:0000305|PubMed:24275660, ECO:0007744|PDB:3HL4,
FT                   ECO:0007744|PDB:4MVC"
FT   BINDING         169
FT                   /ligand="CTP"
FT                   /ligand_id="ChEBI:CHEBI:37563"
FT                   /evidence="ECO:0000305|PubMed:19783652,
FT                   ECO:0000305|PubMed:24275660, ECO:0007744|PDB:3HL4,
FT                   ECO:0007744|PDB:4MVC"
FT   BINDING         173
FT                   /ligand="CTP"
FT                   /ligand_id="ChEBI:CHEBI:37563"
FT                   /evidence="ECO:0000305|PubMed:19783652,
FT                   ECO:0000305|PubMed:24275660, ECO:0007744|PDB:3HL4,
FT                   ECO:0007744|PDB:4MVC"
FT   BINDING         195
FT                   /ligand="CTP"
FT                   /ligand_id="ChEBI:CHEBI:37563"
FT                   /evidence="ECO:0000305|PubMed:19783652,
FT                   ECO:0000305|PubMed:24275660, ECO:0007744|PDB:3HL4,
FT                   ECO:0007744|PDB:4MVC, ECO:0007744|PDB:4MVD"
FT   BINDING         196
FT                   /ligand="CTP"
FT                   /ligand_id="ChEBI:CHEBI:37563"
FT                   /evidence="ECO:0000305|PubMed:19783652,
FT                   ECO:0000305|PubMed:24275660, ECO:0007744|PDB:3HL4,
FT                   ECO:0007744|PDB:4MVC, ECO:0007744|PDB:4MVD"
FT   BINDING         197
FT                   /ligand="CTP"
FT                   /ligand_id="ChEBI:CHEBI:37563"
FT                   /evidence="ECO:0000305|PubMed:19783652,
FT                   ECO:0000305|PubMed:24275660, ECO:0007744|PDB:3HL4,
FT                   ECO:0007744|PDB:4MVC, ECO:0007744|PDB:4MVD"
FT   BINDING         200
FT                   /ligand="CTP"
FT                   /ligand_id="ChEBI:CHEBI:37563"
FT                   /evidence="ECO:0000305|PubMed:19783652,
FT                   ECO:0000305|PubMed:24275660, ECO:0007744|PDB:3HL4,
FT                   ECO:0007744|PDB:4MVC, ECO:0007744|PDB:4MVD"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P49585"
FT   MOD_RES         8
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P49585"
FT   MOD_RES         233
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P49585"
FT   MOD_RES         315
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:8144639"
FT   MOD_RES         319
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8144639,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         321
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8144639"
FT   MOD_RES         322
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8144639"
FT   MOD_RES         323
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8144639"
FT   MOD_RES         325
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P49586"
FT   MOD_RES         329
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8144639"
FT   MOD_RES         331
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8144639,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         333
FT                   /note="Phosphoserine; by PKC"
FT                   /evidence="ECO:0000269|PubMed:8144639"
FT   MOD_RES         342
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         343
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8144639"
FT   MOD_RES         345
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8144639"
FT   MOD_RES         346
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8144639"
FT   MOD_RES         347
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8144639,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         350
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8144639"
FT   MOD_RES         352
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:8144639"
FT   MOD_RES         358
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P49586"
FT   MOD_RES         362
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:8144639,
FT                   ECO:0007744|PubMed:22673903"
FT   MUTAGEN         122
FT                   /note="K->A: Nearly abolishes enzyme activity. Decreases
FT                   affinity for phosphocholine about 500-fold."
FT                   /evidence="ECO:0000269|PubMed:12718547"
FT   MUTAGEN         122
FT                   /note="K->R: Nearly abolishes enzyme activity. Decreases
FT                   affinity for phosphocholine about 80-fold."
FT                   /evidence="ECO:0000269|PubMed:12718547"
FT   MUTAGEN         168
FT                   /note="H->A: Strongly reduced catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:19783652"
FT   MUTAGEN         173
FT                   /note="Y->A: Reduced catalytic activity. Reduces affinity
FT                   for phosphocholine."
FT                   /evidence="ECO:0000269|PubMed:19783652"
FT   MUTAGEN         362
FT                   /note="S->A,C: No loss of enzyme activity and nuclear
FT                   localization."
FT                   /evidence="ECO:0000269|PubMed:8185307"
FT   CONFLICT        91
FT                   /note="G -> S (in Ref. 1; AAA40995)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        114
FT                   /note="S -> C (in Ref. 1; AAA40995)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        116..117
FT                   /note="EL -> DV (in Ref. 2; AAB60489)"
FT                   /evidence="ECO:0000305"
FT   HELIX           48..50
FT                   /evidence="ECO:0007829|PDB:3HL4"
FT   STRAND          55..57
FT                   /evidence="ECO:0007829|PDB:4MVC"
FT   HELIX           64..69
FT                   /evidence="ECO:0007829|PDB:3HL4"
FT   STRAND          73..75
FT                   /evidence="ECO:0007829|PDB:4MVC"
FT   STRAND          77..83
FT                   /evidence="ECO:0007829|PDB:3HL4"
FT   HELIX           90..100
FT                   /evidence="ECO:0007829|PDB:3HL4"
FT   STRAND          102..112
FT                   /evidence="ECO:0007829|PDB:3HL4"
FT   HELIX           115..121
FT                   /evidence="ECO:0007829|PDB:3HL4"
FT   HELIX           129..137
FT                   /evidence="ECO:0007829|PDB:3HL4"
FT   STRAND          139..141
FT                   /evidence="ECO:0007829|PDB:4MVC"
FT   STRAND          143..148
FT                   /evidence="ECO:0007829|PDB:3HL4"
FT   HELIX           155..160
FT                   /evidence="ECO:0007829|PDB:3HL4"
FT   STRAND          165..171
FT                   /evidence="ECO:0007829|PDB:3HL4"
FT   HELIX           183..187
FT                   /evidence="ECO:0007829|PDB:3HL4"
FT   STRAND          191..194
FT                   /evidence="ECO:0007829|PDB:3HL4"
FT   HELIX           202..214
FT                   /evidence="ECO:0007829|PDB:3HL4"
FT   TURN            238..240
FT                   /evidence="ECO:0007829|PDB:1PEH"
FT   STRAND          243..245
FT                   /evidence="ECO:0007829|PDB:1PEH"
FT   HELIX           248..252
FT                   /evidence="ECO:0007829|PDB:1PEH"
FT   HELIX           255..257
FT                   /evidence="ECO:0007829|PDB:1PEH"
FT   TURN            258..260
FT                   /evidence="ECO:0007829|PDB:1PEH"
FT   HELIX           261..267
FT                   /evidence="ECO:0007829|PDB:1PEH"
FT   HELIX           270..274
FT                   /evidence="ECO:0007829|PDB:1PEI"
FT   HELIX           276..291
FT                   /evidence="ECO:0007829|PDB:4MVC"
SQ   SEQUENCE   367 AA;  41681 MW;  44DFFFC0F1608969 CRC64;
     MDAQSSAKVN SRKRRKEVPG PNGATEEDGI PSKVQRCAVG LRQPAPFSDE IEVDFSKPYV
     RVTMEEACRG TPCERPVRVY ADGIFDLFHS GHARALMQAK NLFPNTYLIV GVCSDELTHN
     FKGFTVMNEN ERYDAVQHCR YVDEVVRNAP WTLTPEFLAE HRIDFVAHDD IPYSSAGSDD
     VYKHIKEAGM FAPTQRTEGI STSDIITRIV RDYDVYARRN LQRGYTAKEL NVSFINEKKY
     HLQERVDKVK KKVKDVEEKS KEFVQKVEEK SIDLIQKWEE KSREFIGSFL EMFGPEGALK
     HMLKEGKGRM LQAISPKQSP SSSPTHERSP SPSFRWPFSG KTSPSSSPAS LSRCKAVTCD
     ISEDEED
//
